Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.75482210 |
2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.99608329 |
3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.87034197 |
4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.87034197 |
5 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.61830652 |
6 | negative T cell selection (GO:0043383) | 5.61716595 |
7 | negative thymic T cell selection (GO:0045060) | 5.53335014 |
8 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 5.35340209 |
9 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.32998865 |
10 | regulation of gamma-delta T cell activation (GO:0046643) | 5.22762351 |
11 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.15170682 |
12 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 5.09872143 |
13 | positive thymic T cell selection (GO:0045059) | 5.05415169 |
14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.03995528 |
15 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.76061414 |
16 | thymic T cell selection (GO:0045061) | 4.58801187 |
17 | interferon-gamma production (GO:0032609) | 4.56567153 |
18 | negative regulation of cell killing (GO:0031342) | 4.51967889 |
19 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.51967889 |
20 | positive T cell selection (GO:0043368) | 4.47747632 |
21 | T cell selection (GO:0045058) | 4.44656570 |
22 | regulation of B cell differentiation (GO:0045577) | 4.38836856 |
23 | B cell receptor signaling pathway (GO:0050853) | 4.36026359 |
24 | * response to interleukin-15 (GO:0070672) | 4.31287279 |
25 | T cell migration (GO:0072678) | 4.26689725 |
26 | NIK/NF-kappaB signaling (GO:0038061) | 4.23814081 |
27 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.18926461 |
28 | regulation of T cell tolerance induction (GO:0002664) | 4.17696199 |
29 | positive regulation of B cell differentiation (GO:0045579) | 4.08727378 |
30 | tolerance induction (GO:0002507) | 4.05474954 |
31 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.03038471 |
32 | positive regulation of interleukin-2 production (GO:0032743) | 4.01663451 |
33 | leukocyte aggregation (GO:0070486) | 3.98740943 |
34 | negative regulation of T cell mediated immunity (GO:0002710) | 3.98174960 |
35 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.92272515 |
36 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.91907158 |
37 | positive regulation by symbiont of host defense response (GO:0052509) | 3.89382540 |
38 | modulation by symbiont of host defense response (GO:0052031) | 3.89382540 |
39 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.89382540 |
40 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.89382540 |
41 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.89382540 |
42 | modulation by symbiont of host immune response (GO:0052553) | 3.89382540 |
43 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.88454636 |
44 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.82007558 |
45 | T cell lineage commitment (GO:0002360) | 3.73878007 |
46 | T cell receptor signaling pathway (GO:0050852) | 3.72992537 |
47 | B cell proliferation (GO:0042100) | 3.64601146 |
48 | mast cell activation (GO:0045576) | 3.62972809 |
49 | mature B cell differentiation (GO:0002335) | 3.62393215 |
50 | response to type I interferon (GO:0034340) | 3.62382990 |
51 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.61794793 |
52 | T cell costimulation (GO:0031295) | 3.61721807 |
53 | type I interferon signaling pathway (GO:0060337) | 3.59869582 |
54 | cellular response to type I interferon (GO:0071357) | 3.59869582 |
55 | * cellular response to interleukin-15 (GO:0071350) | 3.57743469 |
56 | lymphocyte costimulation (GO:0031294) | 3.57119311 |
57 | myeloid dendritic cell activation (GO:0001773) | 3.56948086 |
58 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.51380879 |
59 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.51200711 |
60 | defense response to protozoan (GO:0042832) | 3.49379757 |
61 | T cell homeostasis (GO:0043029) | 3.45396679 |
62 | B cell mediated immunity (GO:0019724) | 3.44396012 |
63 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.43968935 |
64 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.41784709 |
65 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.41540953 |
66 | cellular response to zinc ion (GO:0071294) | 3.41452873 |
67 | positive regulation of isotype switching (GO:0045830) | 3.40125784 |
68 | immunoglobulin mediated immune response (GO:0016064) | 3.37827052 |
69 | myeloid dendritic cell differentiation (GO:0043011) | 3.34976380 |
70 | lymphocyte homeostasis (GO:0002260) | 3.33194786 |
71 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.32958062 |
72 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.32902604 |
73 | regulation of B cell proliferation (GO:0030888) | 3.28796671 |
74 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.27743940 |
75 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.27365559 |
76 | negative regulation of interleukin-12 production (GO:0032695) | 3.27341069 |
77 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.27229734 |
78 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.25788048 |
79 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.25294852 |
80 | response to protozoan (GO:0001562) | 3.24387984 |
81 | regulation of regulatory T cell differentiation (GO:0045589) | 3.24079653 |
82 | regulation of antigen processing and presentation (GO:0002577) | 3.21945391 |
83 | positive regulation of antigen processing and presentation (GO:0002579) | 3.21155648 |
84 | detection of bacterium (GO:0016045) | 3.20917622 |
85 | regulation of interleukin-2 production (GO:0032663) | 3.20354808 |
86 | regulation of tolerance induction (GO:0002643) | 3.19997329 |
87 | positive regulation of humoral immune response (GO:0002922) | 3.18638026 |
88 | regulation of response to interferon-gamma (GO:0060330) | 3.17725443 |
89 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.17650637 |
90 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.17011155 |
91 | T-helper 1 type immune response (GO:0042088) | 3.15261998 |
92 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.13957908 |
93 | activated T cell proliferation (GO:0050798) | 3.13147244 |
94 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.11534844 |
95 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.11415789 |
96 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.11346280 |
97 | response to muramyl dipeptide (GO:0032495) | 3.11096014 |
98 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.10766843 |
99 | B cell homeostasis (GO:0001782) | 3.08860676 |
100 | lymph node development (GO:0048535) | 3.07054609 |
101 | regulation of B cell mediated immunity (GO:0002712) | 3.07025744 |
102 | cellular response to interferon-gamma (GO:0071346) | 3.06823599 |
103 | germinal center formation (GO:0002467) | 3.06379572 |
104 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.06371294 |
105 | cellular response to interferon-beta (GO:0035458) | 3.05427529 |
106 | macrophage activation involved in immune response (GO:0002281) | 3.04872681 |
107 | leukocyte homeostasis (GO:0001776) | 3.04850847 |
108 | positive regulation of interferon-alpha production (GO:0032727) | 3.04249812 |
109 | cytidine deamination (GO:0009972) | 3.03754607 |
110 | cytidine metabolic process (GO:0046087) | 3.03754607 |
111 | cytidine catabolic process (GO:0006216) | 3.03754607 |
112 | positive regulation of tolerance induction (GO:0002645) | 3.03471999 |
113 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.01308948 |
114 | positive regulation of DNA recombination (GO:0045911) | 3.01289319 |
115 | regulation of immunoglobulin mediated immune response (GO:0002889) | 2.99607518 |
116 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.98794703 |
117 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.98794703 |
118 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.97693574 |
119 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.97693574 |
120 | regulation of isotype switching (GO:0045191) | 2.96818483 |
121 | positive regulation of B cell activation (GO:0050871) | 2.95390904 |
122 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.94269013 |
123 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.93450884 |
124 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.92946958 |
125 | mast cell activation involved in immune response (GO:0002279) | 2.92699919 |
126 | mast cell degranulation (GO:0043303) | 2.92699919 |
127 | T cell proliferation (GO:0042098) | 2.90790861 |
128 | mature B cell differentiation involved in immune response (GO:0002313) | 2.89839284 |
129 | alpha-beta T cell activation (GO:0046631) | 2.88971936 |
130 | positive regulation of B cell proliferation (GO:0030890) | 2.88673445 |
131 | regulation of B cell activation (GO:0050864) | 2.87649809 |
132 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.87534392 |
133 | positive regulation of B cell mediated immunity (GO:0002714) | 2.87534392 |
134 | regulation of alpha-beta T cell activation (GO:0046634) | 2.87376172 |
135 | positive regulation of cytokine biosynthetic process (GO:0042108) | 2.86718221 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.51746208 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.54851874 |
3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.10972072 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.59694168 |
5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.90870587 |
6 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.56678227 |
7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.49297455 |
8 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.48981148 |
9 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.42504903 |
10 | * MYC_22102868_ChIP-Seq_BL_Human | 3.29404070 |
11 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.25114224 |
12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.15973561 |
13 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.11135207 |
14 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 3.07737788 |
15 | MYB_26560356_Chip-Seq_TH2_Human | 2.96011690 |
16 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.88339677 |
17 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.81822230 |
18 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.81750071 |
19 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.70094473 |
20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.68878339 |
21 | * MAF_26560356_Chip-Seq_TH1_Human | 2.65579021 |
22 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.64902683 |
23 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.61150189 |
24 | * MYB_26560356_Chip-Seq_TH1_Human | 2.53875503 |
25 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.51227041 |
26 | * NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.47906557 |
27 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.47435116 |
28 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.41654968 |
29 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.31286714 |
30 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.29240912 |
31 | UTX_26944678_Chip-Seq_JUKART_Human | 2.27111558 |
32 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.11229951 |
33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.07540751 |
34 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.03515141 |
35 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.02507754 |
36 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.01918791 |
37 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.98506057 |
38 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.87113616 |
39 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.86258095 |
40 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.79424932 |
41 | * MAF_26560356_Chip-Seq_TH2_Human | 1.78937925 |
42 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.77664499 |
43 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76286239 |
44 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.73298379 |
45 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.72631431 |
46 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69929130 |
47 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.62096025 |
48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.60985205 |
49 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.58032144 |
50 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55825027 |
51 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.49624482 |
52 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.44812082 |
53 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42655601 |
54 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.38590363 |
55 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.37200602 |
56 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.34766393 |
57 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.34114368 |
58 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.32484516 |
59 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.28957371 |
60 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24795539 |
61 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.24486911 |
62 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.23049987 |
63 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.22965189 |
64 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.21137977 |
65 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17478768 |
66 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.17248553 |
67 | GATA1_22025678_ChIP-Seq_K562_Human | 1.15041979 |
68 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.13875468 |
69 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13646903 |
70 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.10814556 |
71 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10171413 |
72 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.10055699 |
73 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.07974648 |
74 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.07967782 |
75 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.07963355 |
76 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.07220214 |
77 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.04682012 |
78 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.04179297 |
79 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01507688 |
80 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.00881298 |
81 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.00008753 |
82 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98967333 |
83 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95442311 |
84 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.95263089 |
85 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.94469592 |
86 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.93822223 |
87 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92842494 |
88 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.92471521 |
89 | * GATA3_26560356_Chip-Seq_TH1_Human | 0.91508629 |
90 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.90619551 |
91 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90497606 |
92 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89737658 |
93 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.88209625 |
94 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.86878824 |
95 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83974644 |
96 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82947916 |
97 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.80901670 |
98 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.80485880 |
99 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.80146710 |
100 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79923889 |
101 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.79592088 |
102 | P300_27268052_Chip-Seq_Bcells_Human | 0.77130874 |
103 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.76222921 |
104 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.75282745 |
105 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.74340241 |
106 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.73360190 |
107 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.73307793 |
108 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72195312 |
109 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.71612622 |
110 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.71519893 |
111 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.71095403 |
112 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.69734407 |
113 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.69115257 |
114 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.68710567 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.71745131 |
2 | MP0005671_abnormal_response_to | 4.07859780 |
3 | * MP0003763_abnormal_thymus_physiology | 3.79438316 |
4 | * MP0001800_abnormal_humoral_immune | 3.68827278 |
5 | * MP0000685_abnormal_immune_system | 3.55360378 |
6 | * MP0001790_abnormal_immune_system | 3.48164872 |
7 | * MP0005387_immune_system_phenotype | 3.48164872 |
8 | * MP0005000_abnormal_immune_tolerance | 3.24670446 |
9 | MP0009785_altered_susceptibility_to | 3.10458380 |
10 | * MP0002452_abnormal_antigen_presenting | 3.10394229 |
11 | * MP0002723_abnormal_immune_serum | 3.07415213 |
12 | * MP0002420_abnormal_adaptive_immunity | 2.94924696 |
13 | MP0003436_decreased_susceptibility_to | 2.93369091 |
14 | * MP0001819_abnormal_immune_cell | 2.91139650 |
15 | * MP0002398_abnormal_bone_marrow | 2.74457716 |
16 | * MP0005025_abnormal_response_to | 2.68607998 |
17 | MP0002166_altered_tumor_susceptibility | 2.68492642 |
18 | MP0002396_abnormal_hematopoietic_system | 2.65195337 |
19 | * MP0002148_abnormal_hypersensitivity_rea | 2.63157703 |
20 | * MP0000716_abnormal_immune_system | 2.48464163 |
21 | MP0006082_CNS_inflammation | 2.40796211 |
22 | MP0002405_respiratory_system_inflammati | 2.38939071 |
23 | MP0002419_abnormal_innate_immunity | 2.38931354 |
24 | MP0002006_tumorigenesis | 2.30714141 |
25 | MP0003303_peritoneal_inflammation | 2.30360618 |
26 | MP0004510_myositis | 2.27483542 |
27 | MP0000689_abnormal_spleen_morphology | 2.27172876 |
28 | MP0009333_abnormal_splenocyte_physiolog | 2.24297060 |
29 | MP0001873_stomach_inflammation | 2.17438206 |
30 | * MP0002722_abnormal_immune_system | 2.15079846 |
31 | MP0010155_abnormal_intestine_physiology | 2.13626840 |
32 | MP0000703_abnormal_thymus_morphology | 2.04158468 |
33 | * MP0002429_abnormal_blood_cell | 2.03874553 |
34 | MP0005464_abnormal_platelet_physiology | 2.01495874 |
35 | MP0003724_increased_susceptibility_to | 1.91171451 |
36 | MP0001853_heart_inflammation | 1.89668554 |
37 | MP0004947_skin_inflammation | 1.89002341 |
38 | MP0003866_abnormal_defecation | 1.87601245 |
39 | * MP0001845_abnormal_inflammatory_respons | 1.79621719 |
40 | MP0005645_abnormal_hypothalamus_physiol | 1.75124715 |
41 | MP0002933_joint_inflammation | 1.75033701 |
42 | MP0005310_abnormal_salivary_gland | 1.73276791 |
43 | MP0003300_gastrointestinal_ulcer | 1.71696344 |
44 | MP0004808_abnormal_hematopoietic_stem | 1.66781792 |
45 | MP0005174_abnormal_tail_pigmentation | 1.47216239 |
46 | MP0000465_gastrointestinal_hemorrhage | 1.33880252 |
47 | MP0001533_abnormal_skeleton_physiology | 1.30158616 |
48 | MP0008469_abnormal_protein_level | 1.30090779 |
49 | MP0002138_abnormal_hepatobiliary_system | 1.24230883 |
50 | MP0000490_abnormal_crypts_of | 1.24084913 |
51 | MP0005397_hematopoietic_system_phenotyp | 1.21436229 |
52 | MP0001545_abnormal_hematopoietic_system | 1.21436229 |
53 | MP0008057_abnormal_DNA_replication | 1.15880595 |
54 | MP0005075_abnormal_melanosome_morpholog | 1.13770893 |
55 | MP0003172_abnormal_lysosome_physiology | 1.07854671 |
56 | MP0000858_altered_metastatic_potential | 1.07737948 |
57 | MP0000015_abnormal_ear_pigmentation | 1.03666198 |
58 | MP0001851_eye_inflammation | 0.98883336 |
59 | MP0003448_altered_tumor_morphology | 0.96164966 |
60 | MP0002019_abnormal_tumor_incidence | 0.94634714 |
61 | MP0001348_abnormal_lacrimal_gland | 0.94555065 |
62 | MP0005451_abnormal_body_composition | 0.91141377 |
63 | MP0002009_preneoplasia | 0.88226665 |
64 | MP0009278_abnormal_bone_marrow | 0.87510545 |
65 | MP0002998_abnormal_bone_remodeling | 0.86744970 |
66 | MP0002277_abnormal_respiratory_mucosa | 0.85367820 |
67 | MP0005379_endocrine/exocrine_gland_phen | 0.85325377 |
68 | MP0002095_abnormal_skin_pigmentation | 0.85070211 |
69 | MP0002132_abnormal_respiratory_system | 0.83916879 |
70 | MP0009764_decreased_sensitivity_to | 0.81204202 |
71 | MP0000372_irregular_coat_pigmentation | 0.81192063 |
72 | MP0003183_abnormal_peptide_metabolism | 0.77396462 |
73 | MP0004381_abnormal_hair_follicle | 0.76543981 |
74 | MP0005058_abnormal_lysosome_morphology | 0.74423113 |
75 | MP0008007_abnormal_cellular_replicative | 0.73620047 |
76 | MP0002163_abnormal_gland_morphology | 0.69838486 |
77 | MP0009763_increased_sensitivity_to | 0.66912498 |
78 | MP0003191_abnormal_cellular_cholesterol | 0.66872665 |
79 | MP0003646_muscle_fatigue | 0.66796334 |
80 | MP0008872_abnormal_physiological_respon | 0.64988848 |
81 | MP0003077_abnormal_cell_cycle | 0.63943115 |
82 | MP0001663_abnormal_digestive_system | 0.62920056 |
83 | MP0010352_gastrointestinal_tract_polyps | 0.60128002 |
84 | MP0002136_abnormal_kidney_physiology | 0.59947049 |
85 | MP0008058_abnormal_DNA_repair | 0.59881878 |
86 | MP0002139_abnormal_hepatobiliary_system | 0.59705338 |
87 | MP0009765_abnormal_xenobiotic_induced | 0.58225802 |
88 | MP0010094_abnormal_chromosome_stability | 0.55109286 |
89 | MP0001919_abnormal_reproductive_system | 0.53386936 |
90 | MP0000609_abnormal_liver_physiology | 0.53198880 |
91 | MP0003693_abnormal_embryo_hatching | 0.53170897 |
92 | MP0005390_skeleton_phenotype | 0.53093443 |
93 | MP0008961_abnormal_basal_metabolism | 0.50833241 |
94 | MP0000371_diluted_coat_color | 0.50417335 |
95 | MP0008877_abnormal_DNA_methylation | 0.50176163 |
96 | MP0000249_abnormal_blood_vessel | 0.50109461 |
97 | MP0000313_abnormal_cell_death | 0.49584049 |
98 | MP0008874_decreased_physiological_sensi | 0.49546693 |
99 | MP0002928_abnormal_bile_duct | 0.48346191 |
100 | MP0003045_fibrosis | 0.48008351 |
101 | MP0004742_abnormal_vestibular_system | 0.47775341 |
102 | MP0003828_pulmonary_edema | 0.47437731 |
103 | MP0002254_reproductive_system_inflammat | 0.47437117 |
104 | MP0003795_abnormal_bone_structure | 0.47150206 |
105 | MP0005166_decreased_susceptibility_to | 0.46841982 |
106 | MP0009840_abnormal_foam_cell | 0.46784623 |
107 | MP0006035_abnormal_mitochondrial_morpho | 0.46157064 |
108 | MP0000343_altered_response_to | 0.45900868 |
109 | MP0001191_abnormal_skin_condition | 0.45819582 |
110 | MP0001986_abnormal_taste_sensitivity | 0.45512876 |
111 | MP0000477_abnormal_intestine_morphology | 0.45454760 |
112 | MP0003091_abnormal_cell_migration | 0.45307395 |
113 | MP0000604_amyloidosis | 0.45275599 |
114 | MP0002693_abnormal_pancreas_physiology | 0.44418110 |
115 | MP0005167_abnormal_blood-brain_barrier | 0.44362209 |
116 | MP0005647_abnormal_sex_gland | 0.43532228 |
117 | MP0000569_abnormal_digit_pigmentation | 0.41508988 |
118 | MP0003453_abnormal_keratinocyte_physiol | 0.39621261 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.16513139 |
2 | Recurrent bronchitis (HP:0002837) | 4.92319168 |
3 | IgM deficiency (HP:0002850) | 4.87426529 |
4 | Recurrent fungal infections (HP:0002841) | 4.83624672 |
5 | T lymphocytopenia (HP:0005403) | 4.78878892 |
6 | Chronic otitis media (HP:0000389) | 4.78350818 |
7 | Recurrent viral infections (HP:0004429) | 4.75872321 |
8 | Abnormality of T cell number (HP:0011839) | 4.75165551 |
9 | Eczematoid dermatitis (HP:0000976) | 4.74735427 |
10 | Panhypogammaglobulinemia (HP:0003139) | 4.73010288 |
11 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.71194174 |
12 | Agammaglobulinemia (HP:0004432) | 4.56030622 |
13 | Recurrent abscess formation (HP:0002722) | 4.53439966 |
14 | Myositis (HP:0100614) | 4.44827468 |
15 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.44044877 |
16 | Recurrent cutaneous fungal infections (HP:0011370) | 4.44044877 |
17 | Stomatitis (HP:0010280) | 4.41091156 |
18 | Abnormality of T cells (HP:0002843) | 4.23887861 |
19 | Recurrent bacterial skin infections (HP:0005406) | 4.03359428 |
20 | IgG deficiency (HP:0004315) | 3.97365179 |
21 | Inflammation of the large intestine (HP:0002037) | 3.91599822 |
22 | Meningitis (HP:0001287) | 3.85754736 |
23 | Lymphopenia (HP:0001888) | 3.80324237 |
24 | Nasal polyposis (HP:0100582) | 3.77132945 |
25 | Gastrointestinal inflammation (HP:0004386) | 3.75337340 |
26 | Vasculitis (HP:0002633) | 3.74642254 |
27 | Gastrointestinal stroma tumor (HP:0100723) | 3.69937340 |
28 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.68680589 |
29 | Recurrent skin infections (HP:0001581) | 3.65266248 |
30 | Mediastinal lymphadenopathy (HP:0100721) | 3.61630043 |
31 | Severe combined immunodeficiency (HP:0004430) | 3.61479592 |
32 | Abnormality of T cell physiology (HP:0011840) | 3.59281610 |
33 | B lymphocytopenia (HP:0010976) | 3.44995170 |
34 | Abnormality of B cell number (HP:0010975) | 3.44995170 |
35 | Thyroiditis (HP:0100646) | 3.44780088 |
36 | Colitis (HP:0002583) | 3.44390083 |
37 | Thrombocytosis (HP:0001894) | 3.41384475 |
38 | Cellulitis (HP:0100658) | 3.36106825 |
39 | Combined immunodeficiency (HP:0005387) | 3.32361964 |
40 | Retrobulbar optic neuritis (HP:0100654) | 3.29550858 |
41 | Optic neuritis (HP:0100653) | 3.29550858 |
42 | Abnormality of the nasal mucosa (HP:0000433) | 3.22958814 |
43 | Chronic obstructive pulmonary disease (HP:0006510) | 3.22708861 |
44 | Obstructive lung disease (HP:0006536) | 3.22708861 |
45 | Abnormality of eosinophils (HP:0001879) | 3.11807177 |
46 | Eosinophilia (HP:0001880) | 3.10503466 |
47 | Orchitis (HP:0100796) | 3.09213420 |
48 | IgA deficiency (HP:0002720) | 3.06701063 |
49 | Chronic sinusitis (HP:0011109) | 3.05399183 |
50 | Pustule (HP:0200039) | 2.99737007 |
51 | Abnormality of the fingertips (HP:0001211) | 2.98278370 |
52 | Autoimmune thrombocytopenia (HP:0001973) | 2.97814744 |
53 | Spontaneous hematomas (HP:0007420) | 2.94573147 |
54 | Increased IgM level (HP:0003496) | 2.92277169 |
55 | Leukocytosis (HP:0001974) | 2.91483014 |
56 | Pulmonary infiltrates (HP:0002113) | 2.88567712 |
57 | * Recurrent sinusitis (HP:0011108) | 2.87931712 |
58 | Encephalitis (HP:0002383) | 2.85229428 |
59 | Increased IgE level (HP:0003212) | 2.82899251 |
60 | Granulocytopenia (HP:0001913) | 2.80729087 |
61 | Lymphoma (HP:0002665) | 2.79581718 |
62 | Emphysema (HP:0002097) | 2.79003199 |
63 | Hemoptysis (HP:0002105) | 2.76585737 |
64 | * Chronic diarrhea (HP:0002028) | 2.74383707 |
65 | Basal cell carcinoma (HP:0002671) | 2.69676426 |
66 | Autoimmune hemolytic anemia (HP:0001890) | 2.68454425 |
67 | Bronchitis (HP:0012387) | 2.66591443 |
68 | Abnormality of macrophages (HP:0004311) | 2.63999861 |
69 | Hypergammaglobulinemia (HP:0010702) | 2.63017712 |
70 | Papilloma (HP:0012740) | 2.56236165 |
71 | Verrucae (HP:0200043) | 2.56236165 |
72 | Interstitial pulmonary disease (HP:0006530) | 2.50288573 |
73 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.49035294 |
74 | Arterial thrombosis (HP:0004420) | 2.48032304 |
75 | Urticaria (HP:0001025) | 2.45163857 |
76 | Recurrent pneumonia (HP:0006532) | 2.41364519 |
77 | Prolonged bleeding time (HP:0003010) | 2.41300745 |
78 | Recurrent lower respiratory tract infections (HP:0002783) | 2.39854415 |
79 | Chest pain (HP:0100749) | 2.39241649 |
80 | Abnormality of the pleura (HP:0002103) | 2.35859900 |
81 | Gastrointestinal infarctions (HP:0005244) | 2.34607509 |
82 | Gingivitis (HP:0000230) | 2.29560883 |
83 | Epistaxis (HP:0000421) | 2.29525443 |
84 | Joint swelling (HP:0001386) | 2.29013367 |
85 | Viral hepatitis (HP:0006562) | 2.27806570 |
86 | Osteomyelitis (HP:0002754) | 2.26831848 |
87 | Cheilitis (HP:0100825) | 2.25939747 |
88 | Gingival bleeding (HP:0000225) | 2.24281055 |
89 | Skin rash (HP:0000988) | 2.22391566 |
90 | Restrictive lung disease (HP:0002091) | 2.20554000 |
91 | Petechiae (HP:0000967) | 2.20461277 |
92 | Abnormality of the prostate (HP:0008775) | 2.19454428 |
93 | Keratoconjunctivitis sicca (HP:0001097) | 2.15851912 |
94 | Periodontitis (HP:0000704) | 2.12442729 |
95 | Gangrene (HP:0100758) | 2.12102935 |
96 | Amaurosis fugax (HP:0100576) | 2.11502122 |
97 | Skin ulcer (HP:0200042) | 2.11372014 |
98 | Hypoplasia of the thymus (HP:0000778) | 2.09651179 |
99 | Sepsis (HP:0100806) | 2.08527385 |
100 | Leukopenia (HP:0001882) | 2.03928362 |
101 | Acute hepatic failure (HP:0006554) | 2.02432392 |
102 | Pulmonary embolism (HP:0002204) | 2.01517607 |
103 | Arthralgia (HP:0002829) | 2.01194766 |
104 | Keratoconjunctivitis (HP:0001096) | 1.98510945 |
105 | Squamous cell carcinoma (HP:0002860) | 1.97631178 |
106 | Fatigue (HP:0012378) | 1.97058521 |
107 | Neutropenia (HP:0001875) | 1.96994267 |
108 | Abnormality of male internal genitalia (HP:0000022) | 1.93785749 |
109 | Recurrent otitis media (HP:0000403) | 1.93755397 |
110 | Hematochezia (HP:0002573) | 1.93049572 |
111 | Hypertensive crisis (HP:0100735) | 1.90793423 |
112 | Pulmonary fibrosis (HP:0002206) | 1.89892117 |
113 | Anorexia (HP:0002039) | 1.85149916 |
114 | Keratitis (HP:0000491) | 1.84741532 |
115 | Prostate neoplasm (HP:0100787) | 1.84667786 |
116 | Stomach cancer (HP:0012126) | 1.77773699 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 5.95880230 |
2 | TXK | 3.94681401 |
3 | JAK3 | 3.08151244 |
4 | MAP3K14 | 2.98943104 |
5 | PRPF4B | 2.97565580 |
6 | TYK2 | 2.87211794 |
7 | KIT | 2.63036579 |
8 | BLK | 2.59448724 |
9 | ITK | 2.46226603 |
10 | IKBKE | 2.45969211 |
11 | ZAP70 | 2.42564060 |
12 | CSF1R | 2.21701568 |
13 | TBK1 | 2.21672961 |
14 | BTK | 2.13282238 |
15 | IRAK4 | 2.12353684 |
16 | TEC | 2.07508312 |
17 | PASK | 2.02238291 |
18 | SYK | 1.99224098 |
19 | IKBKB | 1.95085960 |
20 | STK10 | 1.93556742 |
21 | JAK1 | 1.92898886 |
22 | FGFR4 | 1.92508492 |
23 | GRK6 | 1.84849125 |
24 | NLK | 1.82867138 |
25 | LCK | 1.77447290 |
26 | MAP3K13 | 1.71046675 |
27 | SMG1 | 1.58675638 |
28 | TGFBR2 | 1.56061823 |
29 | TLK1 | 1.53564503 |
30 | HCK | 1.53295280 |
31 | NME2 | 1.47822954 |
32 | FLT3 | 1.44378033 |
33 | SIK3 | 1.38765194 |
34 | RIPK4 | 1.35822474 |
35 | CLK1 | 1.35137514 |
36 | CSK | 1.33667872 |
37 | MAP3K10 | 1.33374720 |
38 | MST4 | 1.33220809 |
39 | CHUK | 1.30646570 |
40 | FGFR3 | 1.29600913 |
41 | SIK2 | 1.25716815 |
42 | LYN | 1.25231625 |
43 | EEF2K | 1.15802529 |
44 | EPHB1 | 1.12612001 |
45 | FES | 1.12356225 |
46 | IRAK3 | 1.11111145 |
47 | PIM1 | 1.10405796 |
48 | ZAK | 1.06444698 |
49 | ERN1 | 1.03951459 |
50 | EPHA3 | 1.03378785 |
51 | MARK3 | 1.02023749 |
52 | LRRK2 | 1.01713276 |
53 | RPS6KA4 | 0.99543655 |
54 | FRK | 0.97725000 |
55 | PRKCQ | 0.97130097 |
56 | ADRBK2 | 0.92420766 |
57 | PIM2 | 0.85721402 |
58 | FGR | 0.80982135 |
59 | JAK2 | 0.80019866 |
60 | MAP2K3 | 0.77322138 |
61 | VRK1 | 0.77259565 |
62 | TNK2 | 0.75675002 |
63 | STK24 | 0.75199534 |
64 | CAMKK1 | 0.73153390 |
65 | PRKCH | 0.70348676 |
66 | MAPKAPK3 | 0.69743600 |
67 | KDR | 0.68601735 |
68 | TGFBR1 | 0.61638069 |
69 | IRAK1 | 0.60168928 |
70 | CAMKK2 | 0.60048256 |
71 | TAF1 | 0.56082528 |
72 | CDC42BPA | 0.54650039 |
73 | CDK12 | 0.54581378 |
74 | RPS6KA5 | 0.54122652 |
75 | HIPK2 | 0.52616864 |
76 | MAP3K7 | 0.49706659 |
77 | STK4 | 0.47866698 |
78 | TAOK2 | 0.47599147 |
79 | CDK4 | 0.45114549 |
80 | BRD4 | 0.43540132 |
81 | CCNB1 | 0.39929889 |
82 | BMPR2 | 0.37999476 |
83 | ABL1 | 0.37522190 |
84 | SIK1 | 0.37427331 |
85 | TAOK3 | 0.37351309 |
86 | PDK1 | 0.34588991 |
87 | NEK9 | 0.34044204 |
88 | ALK | 0.34024856 |
89 | MAPK7 | 0.33783918 |
90 | PKN2 | 0.31538648 |
91 | TSSK6 | 0.31478706 |
92 | ACVR1B | 0.31292465 |
93 | PRKD2 | 0.30796718 |
94 | MAPKAPK2 | 0.30631189 |
95 | MELK | 0.30184379 |
96 | TNIK | 0.29187811 |
97 | PRKCD | 0.28895204 |
98 | PIK3CG | 0.28791255 |
99 | INSR | 0.28148691 |
100 | NUAK1 | 0.28101750 |
101 | RPS6KA6 | 0.27451921 |
102 | MAPK4 | 0.26603072 |
103 | MAP2K2 | 0.25990923 |
104 | MAP3K1 | 0.25567864 |
105 | MAPK3 | 0.25440387 |
106 | EGFR | 0.25164286 |
107 | MAPK12 | 0.25094299 |
108 | FYN | 0.24790406 |
109 | MAP2K6 | 0.24616058 |
110 | PDPK1 | 0.24587900 |
111 | EIF2AK3 | 0.23811070 |
112 | CDK9 | 0.23222332 |
113 | IGF1R | 0.23082596 |
114 | TESK2 | 0.21633530 |
115 | MARK2 | 0.21623275 |
116 | GRK7 | 0.21235616 |
117 | MAPK11 | 0.20429544 |
118 | MAP3K11 | 0.19004488 |
119 | MATK | 0.18613728 |
120 | MAP3K5 | 0.18586248 |
121 | YES1 | 0.18110462 |
122 | MAP3K8 | 0.17651429 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.86152989 |
2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.96922974 |
3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.84418476 |
4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.82538190 |
5 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.68599619 |
6 | Measles_Homo sapiens_hsa05162 | 2.65751927 |
7 | * Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.63401179 |
8 | Allograft rejection_Homo sapiens_hsa05330 | 2.54051749 |
9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.51995187 |
10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.39936530 |
11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.36043926 |
12 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.31196210 |
13 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.26399260 |
14 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.17788039 |
15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.02820476 |
16 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 2.01364143 |
17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.99656294 |
18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.80677733 |
19 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.80242344 |
20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.75298649 |
21 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.66809075 |
22 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.54476592 |
23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.51958289 |
24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.50671978 |
25 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.47430136 |
26 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.47238925 |
27 | Influenza A_Homo sapiens_hsa05164 | 1.43876258 |
28 | Viral myocarditis_Homo sapiens_hsa05416 | 1.38986909 |
29 | Hepatitis B_Homo sapiens_hsa05161 | 1.36331374 |
30 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.33583929 |
31 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.31772191 |
32 | Shigellosis_Homo sapiens_hsa05131 | 1.31587068 |
33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.31010728 |
34 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.30955597 |
35 | Legionellosis_Homo sapiens_hsa05134 | 1.28144277 |
36 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.23582540 |
37 | Tuberculosis_Homo sapiens_hsa05152 | 1.21755051 |
38 | Ribosome_Homo sapiens_hsa03010 | 1.17663244 |
39 | Apoptosis_Homo sapiens_hsa04210 | 1.16507323 |
40 | Pertussis_Homo sapiens_hsa05133 | 1.10890960 |
41 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.10740366 |
42 | Malaria_Homo sapiens_hsa05144 | 1.09488618 |
43 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.05107036 |
44 | Asthma_Homo sapiens_hsa05310 | 1.03980819 |
45 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.03090122 |
46 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.01440007 |
47 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.00905186 |
48 | DNA replication_Homo sapiens_hsa03030 | 0.99899993 |
49 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.95071546 |
50 | Platelet activation_Homo sapiens_hsa04611 | 0.94349391 |
51 | HTLV-I infection_Homo sapiens_hsa05166 | 0.92541015 |
52 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.91543081 |
53 | Salmonella infection_Homo sapiens_hsa05132 | 0.90916251 |
54 | Base excision repair_Homo sapiens_hsa03410 | 0.87860891 |
55 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.87672437 |
56 | Hepatitis C_Homo sapiens_hsa05160 | 0.85144884 |
57 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.84044006 |
58 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.83865581 |
59 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.79780047 |
60 | Mismatch repair_Homo sapiens_hsa03430 | 0.78963410 |
61 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.77038758 |
62 | Other glycan degradation_Homo sapiens_hsa00511 | 0.76858810 |
63 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.72648533 |
64 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.70497362 |
65 | Spliceosome_Homo sapiens_hsa03040 | 0.64770142 |
66 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.64670313 |
67 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.60212080 |
68 | Colorectal cancer_Homo sapiens_hsa05210 | 0.60109018 |
69 | Homologous recombination_Homo sapiens_hsa03440 | 0.59672193 |
70 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.58498016 |
71 | Alcoholism_Homo sapiens_hsa05034 | 0.58205207 |
72 | Phagosome_Homo sapiens_hsa04145 | 0.58102166 |
73 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.55740206 |
74 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.54341970 |
75 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.53241815 |
76 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.53163461 |
77 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.51173254 |
78 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.45685989 |
79 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.45162842 |
80 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.44240887 |
81 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.43622744 |
82 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43358845 |
83 | RNA degradation_Homo sapiens_hsa03018 | 0.41254884 |
84 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.40920206 |
85 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.36583779 |
86 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.34371045 |
87 | Endocytosis_Homo sapiens_hsa04144 | 0.33686062 |
88 | Lysosome_Homo sapiens_hsa04142 | 0.33598318 |
89 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.31369402 |
90 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.30928851 |
91 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.30646769 |
92 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.30061090 |
93 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.29138073 |
94 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.28257907 |
95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.28252987 |
96 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.27776408 |
97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.25294929 |
98 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.24628342 |
99 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.24031004 |
100 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.23680465 |
101 | Pathways in cancer_Homo sapiens_hsa05200 | 0.23084511 |
102 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.22089427 |
103 | Insulin resistance_Homo sapiens_hsa04931 | 0.19742134 |
104 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.18697291 |
105 | Prostate cancer_Homo sapiens_hsa05215 | 0.17905054 |
106 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.17884430 |
107 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.17829935 |
108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.17646484 |
109 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.17502777 |
110 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.17317946 |
111 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.14600470 |
112 | Phototransduction_Homo sapiens_hsa04744 | 0.11050853 |
113 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.06236398 |
114 | Endometrial cancer_Homo sapiens_hsa05213 | 0.02927456 |
115 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.02861790 |
116 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.02184597 |
117 | Choline metabolism in cancer_Homo sapiens_hsa05231 | -0.0079240 |